BioSpace News Archive

Johnson & Johnson Medical Devices Companies* announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in its STELLAR** U.S. Investigational Device Exemption (IDE) study.

For the first time in at least 5 years, pneumonia was 1 of the top 10 reported reasons that Canadians went to the emergency department (ED) last year.

YITU healthcare released two brand new products, Intelligent Diagnostic and Treatment Platform for Cancer Screening and CARE.AITM Intelligent 4D Imaging System for Chest CT, at the annual meeting of Radiological Society of North America (RSNA), which is widely acknowledged as the wind vane of the global radiology community.

I-Mab’s Broad and Innovative Pipeline to Leverage TRACON’s U.S. Product Development Solution Platform

Sciton® is announcing the release of ALLURA™, a micro-invasive laser module for rapid fat reduction and skin contraction1 in the submental, neck and chin area.

Pulmatrix, Inc. today announced that it has entered into a securities purchase agreement with an institutional investor, providing for the purchase and sale of 9,375,000 shares of common stock (or common stock equivalents) at a price of $0.32 per share in a registered direct offering, resulting in total gross proceeds of $3.0 million.

inno-train Diagnostik and JETA Molecular announced today that they had entered into a sales and co-development relationship. Under terms of their agreement, inno-train will distribute JETA’s QTRACE® Analysis System in the United States and Europe, with the exception of France.

Leidos announced today that Jason Albanese has been named the Leidos Health Group’s senior vice president of business development.

Realm Therapeutics plc today provides an update on timing of the ongoing formal sale process as part of the previously announced strategic review.

Senior Healthcare Executive with Extensive Integration and Transaction Experience